Member Info for hants

Good to see ezj holding around the same level. The negative contents of the update do indeed appear to have been largely priced in. Ezj are a great airline and the outlook seems broadly positive going forward.

Of course, the macro economic situation could put a spanner in the works for the airline industry on the whole - but unless something pretty bad happens people will still want/need to travel - they'll just sway towards flying with the more competitively priced airlines such as ezj.

It's due tomorrow. I don't believe it will tell us much that we didn't already anticipate.
I think most of the negativity is already priced in and that going forward things will improve.
Hopefully sentiment will improve once the trading update is out of the way.

We are looking for a close above the 200 Moving Average on the daily chart, then we should see the next leg up. Currently we are just banging our heads against it.

Of course, all on the assumption nothing happens in the meantime.

Why has the price of HEMO drifted so much? I've had a flick through the RNS feed and can't see there's any reason for it to be this low? Is it just a slow burner and fickle PI's losing interest?

It's come to my attention from a trading analysis point of view, looks like it could move up. But it's such a long way off all time highs it looks like it could be an an appealing buy and hold.

We need to push through the 200ma which is just above our heads at the moment, then we should see £2. Be too much profit taking for that to happen today IMO, but maybe tomorrow or Friday.

Exactly multibens.

If the gap fill happens, hopefully nobody on this board will now panic sell at the bottom only to watch it rise again.

Puggle,

Open up your chart and set it to 1 Day. If you go back in time, you'll sell the price gapped up, leaving a 'gap' in the chart. (Think it was 2nd week of Feb). We are probably going to drop back through that gap, which has a bottom at around 155p.

Traders will look for that as an entry point. If you add stochastics to your chart, you'll see we are well into oversold. As we come out of oversold, that's an example of a basic buy signal.

DOH, fundamentals will always override trading analysis. There's no argument from me there. But if you don't believe in charts then you're a fool. Even if you don't want to trade, they help to time your entry and exit points. I believe in Avacta, but I'm only here to make money. If I get the chance to sell and buy back cheaper/accumulate free shares, I'll take it every time.

There is a good reason for the drop, there's a gap fill down to 155 which is probably going to play out (we've dropped well past the important 175 level). You can either trade it to your advantage or ride it out. The charts are in control at the moment.

The reason they're all out today is to get try and encourage some sells and help the share price on it's way down through the gap fill. Once the gap fill has been completed, we should see a reversal. All the bashers will buy in and take the trade, which should bring us quickly back up by 10% or so, followed by some profit taking.

This share is being traded for the time being so expect volatility.

It will probably hold just above the gap at 172 ish and decide what it wants to do. At that point, if it moves down then it will do so very sharply to 153 ish. Traders will look for the bounce, we'll be well into oversold territory

This may not play out today, but the standard 8am drop we see pretty much every morning might give it the nudge over the edge.

Then we'll probably have the standard 10%+ bounce back to 170 or so until the traders take profit. Then pobably trade sideways until something fundamental changes.

Your chart interpretation is fair and I agree 155p now looks likely to be hit. The presentation didn't deliver, it told us nothing new and also we learned that we have lost BBI. We are now on a downwards trajectory.

But you've made yourself look ridiculous with your interpretation of what 'non-exclusive' means.

There was a gap fill down on the charts and it happened very quickly. Hopefully hold this level now.

I'm not expecting much of substance, but I do help we get some little nuggets of information such as manufacturing capacity. We need something which tells investors why to stay in, especially on a red day like today.

Too much waffle and 'shortly' and we'll be going down further. Lets hope Al is paying attention. Equally, trying to draw attention away from the LFT won't be viewed well either. It's all the market is currently focussed on and is the sole reason for the share price being at this level in the first place.

Mr A, I've just seen one of my friends who's RAF and lives in the Netherlands. He's come over here on a visit with his partner. For the two of them to travel here, the PCR testing runs at around £700 due to the need for testing on both sides.

Clearly this is not viable for many people and a different solution is needed.

Lots of people are at risk because they don't look after themselves. Being obese is one of the major risk factors which never seems to get discussed because it's not PC these days. It's one of the reasons the US death toll is so bad.

Should a person who eats healthy food, exercises and looks after themselves - but who isn't vaccinated be refused treatment?

Meanwhile, a person who is unhealthy, eats endless junk and is obese - but who is vaccinated is given treatment?

Whats the difference?

This topic has been covered many times. If the Government want it to be for home use, they will just do the same again - put it in their NHS packaging and get the MHRA to make it so, like they did with Innova.

It's an easier test to use. Don't see this as an obstacle personally.

Exactly Timster. I think PI's forget these funds don't try and nail their entry and exit points down to a few pence, because they can't. Positions have to be slowly built and slowly sold off unless it's share with big trading volumes. They would have to pay well over the ask or sell well below the bid in order to get any volume on Avacta to complete their trades.

Furthermore, when they've seen good returns they will take profits and reduce their exposure. The funds are about consistent performance over a period of time. PI's are about making money quickly and are generally prepared to take more risk, from what I've seen anyway.

I'm pretty sure there was a fund who sold out of Avacta just before the share price took off in the spring of last year. It really doesn't mean anything.

Great RNS, I think this one has arrived more quickly than any of us expected us too. Really pleased to see another one released intraday. It should help to stop the 'sell on the bell' crew when there's no RNS at 7am, which results in the share price being eroded daily during quieter periods.

I've also jumped on the bangwagon of contacting the UK newspapers.

Hopefully at least a couple will take note and run the story. It's great news for us, but there's no real pressure on HMG until the British public are aware of this information.

Exactly manybens, and if you put that comment alongside the capacity issue I've mentioned below the two things fit together.

Equally, it could just mean Innova are going to be knocking them out in Wales instead.

Looking on Bidstats (very briefly, not in detail) the first Innova order was on 19 October and the big ones started in November. So that's 33 weeks ago.

1b divided by 25m is 40. So that's 40 weeks. I appreciated it wouldn't have been 25m per week straight out the gates, of course. This is just some very approximate maths.

Bad news for us, as it would be that in the absolute best case scenario there's still another 7 weeks of Innova tests left, in reality there's way more than that.

BUT...

We would be unable to fill that capacity immediately anyway, so in the event we are the so called 'sovereign test' it's likely to be the case that Innova are phased out whilst we are phased in. Even if our test were to be chosen as the UK's new LFT of choice, we couldn't replace Innova immediately as we wouldn't be able to make them fast enough.

Something interesting to take away from this article is it states the UK is getting through 25m lateral flow tests per week.

Do we have any information on how many lateral flow tests HMG bought for it's 1.2 billion quid? That would tell us long the current stockpiles might last.